Resurrect Bio Secures $10.3 Million to Enhance Plant Disease Resistance Technology
Trendline

Resurrect Bio Secures $10.3 Million to Enhance Plant Disease Resistance Technology

What's Happening? Resurrect Bio, a UK-based startup, has successfully closed its Series A funding round at $10.3 million, with the investment led by Corteva through its Corteva Catalyst platform. The funding round also saw participation from Calculus Capital, Pymwymic, Future Planet Capital (UKI2S),
Summarized by AI
AI Generated
This may include content generated using AI tools. Glance teams are making active and commercially reasonable efforts to moderate all AI generated content. Glance moderation processes are improving however our processes are carried out on a best-effort basis and may not be exhaustive in nature. Glance encourage our users to consume the content judiciously and rely on their own research for accuracy of facts. Glance maintains that all AI generated content here is for entertainment purposes only.